rethinkPeptides Search
Menu
Study breakdown

Developing Antibodies Against Thymosin Alpha-1's Precursor Prothymosin Alpha for Research

In VitroPreliminary evidence
The takeaway

Specific antibodies against prothymosin alpha were developed and validated for immunochemical detection, enabling research into prothymosin alpha's role in gene regulation, cell proliferation, and immune function.

Key finding

Antibodies against poorly immunogenic prothymosin alpha were developed through peptide immunization strategies, enabling immunochemical detection of t

What the researchers found

Antibodies against poorly immunogenic prothymosin alpha were developed through peptide immunization strategies, enabling immunochemical detection of this thymosin alpha-1 precursor in tissues and cells for research applications.

Why it matters

Relevant for thymosin-alpha-1, immune-function, peptide-design.

How the study worked

in-vitro study on thymosin-alpha-1, immune-function.

What this study cannot tell us

See abstract.

How to read the evidence

preliminary evidence.

When this study was published

Published in 2006.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.
  • Clinical translation to evaluate.

Common questions

What was studied?
Developing Antibodies Against Thymosin Alpha-1's Precursor Prothymosin Alpha for Research
What was found?
Specific antibodies against prothymosin alpha were developed and validated for immunochemical detection, enabling research into prothymosin alpha's role in gene regulation, cell proliferation, and immune function.

Read the original research

Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha.

Peptides, 27(1), 183-93

Citation

Klimentzou, Persefoni; Paravatou-Petsotas, Maria; Zikos, Christos; Beck, Alexander; Skopeliti, Margarita; Czarnecki, Jan; Tsitsilonis, Ourania; Voelter, Wolfgang; Livaniou, Evangelia; Evangelatos, Gregory P. (2006). Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha.. Peptides, 27(1), 183-93.